{"id":"W3092875350","doi":"10.14740/wjon1333","title":"Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial","year":2020,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epirubicin; Febrile neutropenia; Internal medicine; Neutropenia; Cyclophosphamide; Chemotherapy; Breast cancer; Docetaxel; Oncology; Gastroenterology; Neoadjuvant therapy; Trastuzumab; Anthracycline; Surgery; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001594632,0.001319008,0.001754722,0.000338327,0.0003064212,0.0008552326,0.0008198872,0.001250186,0.002177532],"category_scores_gemma":[0.0007068848,0.0005425133,0.001006454,0.0003952279,0.0007257689,0.0005675209,0.0002916569,0.002645666,0.0006472372],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007808673,"about_ca_system_score_gemma":0.001642365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007319378,"about_ca_topic_score_gemma":0.00222409,"domain_scores_codex":[0.9996275,0.0002061181,0.00002534023,0.00004351293,0.00003488248,0.00006257273],"domain_scores_gemma":[0.9994574,0.00009677653,0.00009703456,0.00005360352,0.0000341625,0.0002610433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7592143,0.08014679,0.00423574,0.001588667,0.001229678,0.0004704352,0.0002518658,0.002452682,0.03848059,0.000210308,0.002859254,0.1088596],"study_design_scores_gemma":[0.7131405,0.2769649,0.00362739,0.00006483155,0.0003497088,0.0003090305,0.00002842379,0.0008731555,0.002912854,0.00007832374,0.001633561,0.000017319],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915244,0.003806749,0.0003538834,0.0004162838,0.0002143607,0.00202374,0.0003377646,0.00005994115,0.001262763],"genre_scores_gemma":[0.9819734,0.00558177,0.002295436,0.001053125,0.000382325,0.004162106,0.001729013,0.00002909547,0.002793734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002177532,"threshold_uncertainty_score":0.008433342,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01637394088669565,"score_gpt":0.3277154541750859,"score_spread":0.3113415132883903,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}